Janey N. Parsons - Concepedia

Concepedia

Author

Janey N. Parsons

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J N Parsons, J Parsons, J.N. Parsons, Janey N Parsons, Janey N. Parsons, Janey Parsons

12

Publications

1.1K

Citations

11

H-Index

40

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Pennsylvania United States Military Academy

JN

About

Janey N. Parsons is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	861
2	Biochemistry	4	4	592
3	Natural Sciences	3	3	475
4	Cell Biology	3	3	318
5	Allergy	2	2	203

Janey N. Parsons

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding Betsy Frantz, Tracey Klatt, Margaret Pang, Biochemistry P38 Kinase ActivityPyridinylimidazole Inhibitor BindingP38 KinaseMolecular BiologyActivation State	1998	200
Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase Nigel J. Liverton, John W. Butcher, Christopher F. Claiborne, Journal of Medicinal Chemistry ImmunologyPharmacotherapyChemical BiologyPharmaceutical ChemistryInflammation	1999	196
Effect of corticosteroids on the human monocyte IgG and complement receptors. Alan D. Schreiber, Janey N. Parsons, P McDermott, Journal of Clinical Investigation Clinical ImmunologyImmune RegulationImmunologyComplement Receptor FunctionGlucocorticoid	1975	184
Pyrroles and other heterocycles as inhibitors of P38 kinase Stephen E. de Laszlo, Denise M. Visco, Lily Agarwal, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineP38 KinaseAnti-cancer AgentHeterocycle Chemistry	1998	117
Analysis of IL-1 and TNF-<i>alpha</i> gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. Karen L. MacNaul, Nancy I. Hutchinson, Janey N. Parsons, The Journal of Immunology	1990	114
Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation Stephen J. O’Keefe, John S. Mudgett, Susan Cupo, Journal of Biological Chemistry	2007	80
Activation of JNK3α1 Requires both MKK4 and MKK7: Kinetic Characterization of in Vitro Phosphorylated JNK3α1 JeanMarie Lisnock, Patrick R. Griffin, Jimmy Calaycay, Biochemistry Molecular RegulationKinetic CharacterizationCellular PhysiologyJnk3α1 RequiresSignaling Pathway	2000	79
Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex. Janey N. Parsons, Greg Wiederrecht, Scott P. Salowe, Journal of Biological Chemistry	1994	63
The Immunosuppressant FK-506 Specifically Inhibits Mitogen- Induced Activation of the Interleukin-2 Promoter and the Isolated Enhancer Elements NFIL-2A and NF-AT1 Sunandita S. Banerji, Janey N. Parsons, Michael J. Tocci Molecular and Cellular Biology ImmunologyImmune RegulationImmunologic MechanismImmunotherapyInflammation	1991	39
A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH BIOCHEMICAL PROPERTIES DISTINCT FROM THOSE OF TACROLIMUS Laurence B. Peterson, John G. Cryan, Ray Rosa, Transplantation Medicinal ChemistrySignal TransductionFkbp12-indolyl-asc ComplexMedicineImmunosuppressive Therapy	1998	27

Page 1